A second study (after MAINRITSAN) showing the superiority of rituximab vs. azathioprine for maintenance of remission in ANCA-associated vasculitis, by Dr. Rona Smith #ACR19 @rheumnow #Abstr  #ACRBest https://t.co/H8VJiFhp6z